If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
860.00    -62.00 (-6.72%)
Bid:
874.00
Ask:
888.00
Spread: 14.00 (1.602%)
Market Cap: £235.39m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

Half Year Trading Update

5 Apr 2017 07:00

RNS Number : 5892B
Gooch & Housego PLC
05 April 2017
 

For immediate release

5 April 2017

 

 

Gooch & Housego PLC

("G&H" or the "Company")

 

Half Year Trading Update

 

"Full year trading remains in line with management's expectations"

Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of optical components & systems, announces that trading in the six months to 31 March 2017 has been good and the Company expects full year trading to be in line with management's expectations.

Market conditions remain mainly positive, driven in large part by the telecommunications and industrial sectors, in particular high reliability fibre couplers for undersea cables, precision inspection equipment and critical components used in microelectronic manufacturing.

First half revenue growth has been very good, albeit benefitting from a favourable foreign exchange environment and a relatively weak comparator period. Further investment has been necessary to enable us to take advantage of a strong order book.

Our order book stood at a record £66.6 million, as at 31 March 2017, which represents an increase of 70.5% compared with the same time last year. Excluding the impact of foreign exchange and acquisitions this represents an increase of 17.2% over last year.

We are pleased with the overall performance of our recent acquisitions. Kent Periscopes and Alfalight were acquired last year and StingRay was acquired in February of this year.

Our performance improvement programme has progressed well. Lean manufacturing is now adopted more broadly across our sites, we have continued to benefit from concentrating our R&D effort on fewer high return projects and enhanced business development activity.

The Company's Interim Results, for the six months ended 31 March, are expected to be announced on Tuesday 6 June 2017.

Mark Webster, Chief Executive Officer of Gooch & Housego commented:

'G&H is well positioned to take advantage of the mainly positive market conditions and has continued to invest in people and infrastructure to meet the demands of a strong order book'.

'We remain committed to our strategy of diversification and moving up the value chain. This has been most evident in the A&D sector where our most recent acquisitions, combined with investment in R&D has gone some way towards achieving our goal of establishing 'critical mass' in this sector".

'G&H will continue to invest in our performance improvement programme, which will underpin our future growth'.

 

 

 

 

For further information contact: -

 

Mark Webster / Andrew Boteler

Gooch & Housego PLC

01460 256440

Mark Court / Sophie Cowles

Buchanan

020 7466 5000

Patrick Robb / David Anderson

Investec Bank plc

020 7597 5970

 

 

Notes to editors

 

1. Gooch & Housego is a photonics technology business headquartered in Ilminster, Somerset, UK with operations in the USA and Europe. A world leader in its field, the company researches, designs, engineers and manufactures advanced photonic systems, components and instrumentation for applications in the Aerospace & Defence, Industrial, Life Sciences and Scientific Research sectors. World leading design, development and manufacturing expertise is offered across a broad range of complementary technologies.

 

2. All financial information included in this announcement is sourced from unaudited management accounts and excludes any specific items. This announcement contains certain forward-looking statements that are based on management's current expectations or beliefs as well as assumptions about future events. These are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the countries and sectors in which G&H operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results, and G&H's plans and objectives, to differ materially from those currently anticipated or implied in the forward-looking statements. Investors should not place undue reliance on any such statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSSSFMLFWSEDL
Date   Source Headline
3rd Dec 20137:00 amRNSPreliminary Results
26th Nov 20137:00 amRNSAcquisition of Constelex Technology Enablers Ltd
1st Nov 20137:00 amRNSNotification of Preliminary Results
29th Oct 201312:06 pmRNSHolding(s) in Company
15th Oct 201310:17 amRNSHolding(s) in Company
15th Oct 20137:00 amRNSAcquisition of Spanoptic Limited
8th Oct 201311:21 amRNSHolding(s) in Company
7th Oct 20137:00 amRNSFull-Year Trading Update
1st Oct 201311:52 amRNSHolding(s) in Company
18th Sep 20137:00 amRNSCapital Markets Day
9th Sep 20132:38 pmRNSHolding(s) in Company
25th Jul 20135:54 pmRNSHolding(s) in Company
25th Jul 20135:52 pmRNSHolding(s) in Company
12th Jul 20133:12 pmRNSDirector/PDMR Shareholding
12th Jul 20133:11 pmRNSDirector/PDMR Shareholding
12th Jul 20133:09 pmRNSDirector/PDMR Shareholding
12th Jul 20133:07 pmRNSDirector/PDMR Shareholding
12th Jul 20133:05 pmRNSDirector/PDMR Shareholding
11th Jun 20137:00 amRNSSales and Marketing drive
11th Jun 20137:00 amRNSInterim Report
9th May 20137:00 amRNSNotification of Interim Results
10th Apr 20137:00 amRNSNew Long Term Incentive Plan and grant of Awards
8th Apr 20137:00 amRNSHalf Year Trading Update
19th Mar 201310:44 amRNSAnnual Report and Accounts
15th Mar 201310:50 amRNSHolding(s) in Company
1st Mar 20134:09 pmRNSDirector/PDMR Shareholding
1st Mar 20134:05 pmRNSDirector/PDMR Shareholding
1st Mar 20134:03 pmRNSDirector/PDMR Shareholding
1st Mar 20134:01 pmRNSDirector/PDMR Shareholding
28th Feb 20137:00 amRNSResults of Annual General Meeting
27th Feb 201311:24 amRNSAIM Disclosure Update
27th Feb 20137:00 amRNSTrading Update
4th Feb 20133:00 pmRNSAdditional Listing
18th Jan 20132:12 pmRNSDirector/PDMR Shareholding
18th Jan 20132:11 pmRNSDirector/PDMR Shareholding
18th Jan 20132:09 pmRNSDirector/PDMR Shareholding
10th Jan 20133:00 pmRNSAdditional Listing
7th Jan 20137:00 amRNSValue Creation Plan Crystallises
13th Dec 20124:43 pmRNSHolding(s) in Company
27th Nov 20127:00 amRNSPreliminary Results
23rd Oct 20129:34 amRNSHolding(s) in Company
15th Oct 201211:02 amRNSHolding(s) in Company
5th Oct 20127:00 amRNSDirector change
4th Oct 20127:00 amRNSFull-Year Trading Update
25th Sep 20129:53 amRNSHolding(s) in Company
24th Sep 20122:09 pmRNSAdditional Listing
19th Sep 20128:47 amRNSAdditional Listing
19th Sep 20128:45 amRNSDirector/PDMR Shareholding
4th Sep 20122:14 pmRNSHolding(s) in Company
4th Sep 201210:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.